CAS 15966-93-5 VEGFR2 Kinase Inhibitor I - CAS 15966-93-5 - Analytical Products / Alfa Chemistry

CAT	AP15966935
CAS	15966-93-5
Molecular Weight	310.35

Description	The VEGFR2 Kinase Inhibitor I, also referenced under CAS 15966-93-5, controls the biological activity of VEGFR2 Kinase. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications.
Solubility	ethanol: 1 mg/mL; DMSO: 10 mg/mL
Assay	≥95% (HPLC)
Color	yellow
Form	solid; protect from light
Size	1MG
Storage Conditions	-20C

1

Blocking Autocrine VEGF Signaling by Sunitinib, an Anti-Cancer Drug, Promotes Embryonic Stem Cell Self-Renewal and Somatic Cell Reprogramming

Guofang Chen, Xinxiu Xu, Lihong Zhang, Yanbin Fu, Min Wang, Haifeng Gu, Xin Xie

Cell Res. 2014 Sep;24(9):1121-36.

PMID: 25145356

1

DCLAK11, a Multi-Tyrosine Kinase Inhibitor, Exhibits Potent Antitumor and Antiangiogenic Activity in Vitro

Xiao-Bin Guo, Xian-Jie Chen, Lin-Jiang Tong, Xia Peng, Min Huang, Hong-Chun Liu, Hong Liu, Jian Ding

Acta Pharmacol Sin. 2015 Oct;36(10):1266-76.

PMID: 26027659

1

Exploring Binding Mechanisms of VEGFR2 With Three Drugs Lenvatinib, Sorafenib, and Sunitinib by Molecular Dynamics Simulation and Free Energy Calculation

Yu Wang, Cheng Peng, Guimin Wang, Zhijian Xu, Yongfeng Luo, Jinan Wang, Weiliang Zhu

Chem Biol Drug Des. 2019 May;93(5):934-948.

PMID: 30689282

1

Novel Promising 4-anilinoquinazoline-based Derivatives as Multi-Target RTKs Inhibitors: Design, Molecular Docking, Synthesis, and Antitumor Activities in Vitro and Vivo

Peng Xu, Jiarui Chu, Yuqiao Li, Yaping Wang, Yong He, Chuanmin Qi, Jin Chang

Bioorg Med Chem. 2019 Oct 15;27(20):114938.

PMID: 31488358

1

Sulfonamides: A Patent Review (2008 - 2012)

Fabrizio Carta, Andrea Scozzafava, Claudiu T Supuran

Expert Opin Ther Pat. 2012 Jul;22(7):747-58.

PMID: 22697257

* Products or Services Interested: VEGFR2 Kinase Inhibitor I - CAS 15966-93-5 (15966-93-5)
* Your question
* Name
* Email
Verification Code